fda bpc-157 not approved human use warning This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the will make FDA's Overreach on Compounded Peptides

FDA's Overreach on Compounded Peptides 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval Peptides: FDA Loosens Restrictions Despite Concerns From Scientists An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition

SKU: 57553229210 · From www.paramparam.eu